Low-grossing ‘High’ to shutter

Turner topliner ends its Broadway run April 24

B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening.

The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play in the Booth Theater, one of Broadway’s smaller houses.

Strong reviews would have been required to boost sales, but critical response was largely downbeat even if Turner herself earned praise for her perf. Actress stars as a foul-mouthed nun who counsels a young drug addict played by Evan Jonigkeit.

Helmed by Rob Ruggiero, the play, by Matthew Lombardo (“Looped”) originated in a three-city circuit of regional theaters, beginning with TheaterWorks in Hartford, Conn. Turner and Jonigkeit have been with the show since its preem, while fellow cast member Stephen Kunken came aboard for the Main Stem incarnation.

Leonard Soloway and Chase Mishkin lead the producing team of the show, which shutters Sunday.

More Legit

  • Skintight review

    Off Broadway Review: ‘Skintight’ With Idina Menzel

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • Sugar in Our Wounds

    Off Broadway Review: ‘Sugar in Our Wounds’

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • SPRINGSTEEN ON BROADWAY

    Bruce Springsteen Condemns Trump's 'Inhumane' Border Policy During Broadway Show

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • Kenya Barris and Pharrell Williams

    Kenya Barris, Pharrell Williams to Collaborate on Juneteenth Stage Musical

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • BD Wong

    Stagecraft Podcast: BD Wong Talks Basketball in Beijing, Dinosaurs and Batman

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • Michael Jackson Musical Coming to Broadway

    Michael Jackson Musical Coming to Broadway in 2020

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

  • Watch Tom Hanks Vamp on Stage

    Watch Tom Hanks Vamp on Stage to Calm His 'Henry IV' Audience

    B.O.-challenged Broadway play “High” will bow out quickly, setting a closing date for less than a week after its April 19 opening. The Kathleen Turner topliner has been plagued by low sales since it began previews March 25. Weekly receipts have never topped the $100,000 mark, an ultra-low showing even for an unknown new play […]

More From Our Brands

Access exclusive content